| 2024-01-05 | Sale | 2seventy bio, Inc. TSVT | Chief Operating Officer | 1,380 0.0027% | $3.75 | $5,180 | +19.69% | |
| 2024-01-03 | Sale | 2seventy bio, Inc. TSVT | Chief Operating Officer | 33,651 0.0665% | $3.87 | $130,179 | +18.76% | |
| 2023-08-22 | Sale | 2seventy bio, Inc. TSVT | Chief Financial Officer | 7,031 0.0139% | $5.49 | $38,576 | -23.77% | |
| 2023-08-03 | Sale | 2seventy bio, Inc. TSVT | Chief Financial Officer | 6,906 0.0137% | $6.13 | $42,304 | -30.49% | |
| 2023-02-13 | Sale | 2seventy bio, Inc. TSVT | Chief Financial Officer | 637 0.0015% | $12.86 | $8,192 | -53.27% | |
| 2023-01-11 | Sale | 2seventy bio, Inc. TSVT | Chief Financial Officer | 1,077 0.0025% | $10.63 | $11,446 | -12.63% | |
| 2023-01-09 | Sale | 2seventy bio, Inc. TSVT | Chief Financial Officer | 3,222 0.0074% | $10.33 | $33,298 | -10.61% | |
| 2022-08-05 | Sale | 2seventy bio, Inc. TSVT | Chief Financial Officer | 4,152 0.0105% | $16.23 | $67,397 | -28.06% | |
| 2022-07-15 | Sale | 2seventy bio, Inc. TSVT | Chief Financial Officer | 4,080 0.0106% | $13.81 | $56,344 | -8.13% | |
| 2022-02-17 | Sale | 2seventy bio, Inc. TSVT | Chief Financial Officer | 427 0.0016% | $14.78 | $6,311 | -1.19% | |
| 2022-01-07 | Sale | 2seventy bio, Inc. TSVT | Chief Financial Officer | 896 0.0034% | $23.91 | $21,421 | -38.51% | |
| 2021-02-17 | Sale | bluebird bio, Inc. BLUE | Chief Financial Officer | 693 0.001% | $28.16 | $19,516 | -23.77% | |
| 2021-02-12 | Sale | bluebird bio, Inc. BLUE | Chief Financial Officer | 1,216 0.0018% | $45.52 | $55,352 | -49.37% | |
| 2021-01-06 | Sale | bluebird bio, Inc. BLUE | Chief Financial Officer | 949 0.0014% | $45.05 | $42,756 | -38.77% | |
| 2020-02-13 | Sale | bluebird bio, Inc. BLUE | Chief Financial Officer | 1,254 0.0023% | $90.60 | $113,612 | -37.76% | |
| 2018-10-15 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | 20,000 0.0057% | $7.34 | $146,775 | -3.87% | |
| 2018-07-02 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | 20,000 0.0107% | $15.63 | $312,584 | -20.87% | |
| 2018-04-02 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | 20,000 0.0063% | $8.36 | $167,148 | -7.1% | |
| 2018-01-02 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | 20,000 0.0064% | $8.58 | $171,681 | -6% | |
| 2017-10-12 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | 80,000 0.0293% | $8.39 | $670,932 | +1.4% |